159 related articles for article (PubMed ID: 31035006)
1. Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity.
Park JS; Lee YS; Lee DH; Bae SH
Free Radic Biol Med; 2019 Jun; 137():143-157. PubMed ID: 31035006
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
3. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
[TBL] [Abstract][Full Text] [Related]
4. N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice.
Bhagat HA; Compton SA; Musso DL; Laudeman CP; Jackson KMP; Yi NY; Nierobisz LS; Forsberg L; Brenman JE; Sexton JZ
PLoS One; 2018; 13(10):e0204605. PubMed ID: 30359371
[TBL] [Abstract][Full Text] [Related]
5. PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway.
Lee DH; Park JS; Lee YS; Bae SH
Redox Biol; 2022 Apr; 50():102235. PubMed ID: 35091323
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2.
Bathish B; Robertson H; Dillon JF; Dinkova-Kostova AT; Hayes JD
Free Radic Biol Med; 2022 Aug; 188():221-261. PubMed ID: 35728768
[TBL] [Abstract][Full Text] [Related]
7. Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice.
Guo J; Tao H; Alasadi A; Huang Q; Jin S
Eat Weight Disord; 2019 Feb; 24(1):91-96. PubMed ID: 28780747
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
9. Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress.
Zhang MH; Li J; Zhu XY; Zhang YQ; Ye ST; Leng YR; Yang T; Zhang H; Kong LY
Free Radic Biol Med; 2021 Feb; 164():1-12. PubMed ID: 33388433
[TBL] [Abstract][Full Text] [Related]
10. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(1):131-7. PubMed ID: 26325428
[TBL] [Abstract][Full Text] [Related]
11. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.
Chen X; Xue H; Fang W; Chen K; Chen S; Yang W; Shen T; Chen X; Zhang P; Ling W
Redox Biol; 2019 Feb; 21():101068. PubMed ID: 30684890
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway.
Hosseini H; Teimouri M; Shabani M; Koushki M; Babaei Khorzoughi R; Namvarjah F; Izadi P; Meshkani R
Int J Biochem Cell Biol; 2020 Feb; 119():105667. PubMed ID: 31838177
[TBL] [Abstract][Full Text] [Related]
13. Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice.
Tao H; Zhang Y; Zeng X; Shulman GI; Jin S
Nat Med; 2014 Nov; 20(11):1263-9. PubMed ID: 25282357
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
[TBL] [Abstract][Full Text] [Related]
15. Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system.
Yan C; Sun W; Wang X; Long J; Liu X; Feng Z; Liu J
Mol Nutr Food Res; 2016 May; 60(5):1139-49. PubMed ID: 26989875
[TBL] [Abstract][Full Text] [Related]
16. Nanoplastic propels diet-induced NAFL to NASH via ER-mitochondrial tether-controlled redox switch.
Wei J; Liu J; Wang H; Wen K; Ni X; Lin Y; Huang J; You X; Lei Z; Li J; Shen H; Lin Y
J Hazard Mater; 2024 Mar; 465():133142. PubMed ID: 38061129
[TBL] [Abstract][Full Text] [Related]
17. Activation of p62-keap1-Nrf2 antioxidant pathway in the early stage of acetaminophen-induced acute liver injury in mice.
Shen Z; Wang Y; Su Z; Kou R; Xie K; Song F
Chem Biol Interact; 2018 Feb; 282():22-28. PubMed ID: 29331651
[TBL] [Abstract][Full Text] [Related]
18. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease.
Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD
Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698
[TBL] [Abstract][Full Text] [Related]
19. Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related Factors in Nonalcoholic Steatohepatitis Rats.
Wang DJ; Cai YQ; Pan SZ; Zhang LZ; Chen YX; Chen FM; Jin M; Yan MX; Li XD; Chen ZY
Chin J Integr Med; 2018 Apr; 24(4):265-271. PubMed ID: 26919834
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]